← Back to Clinical Trials
Recruiting NCT05001087

NCT05001087 A "Physician & Patient-powered" Cohort Registry (MY MYELOMA)

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05001087
Status Recruiting
Phase
Sponsor Fondazione EMN Italy Onlus
Condition Multiple Myeloma
Study Type OBSERVATIONAL
Enrollment 1,900 participants
Start Date 2021-03-16
Primary Completion 2027-03-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Observation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 1,900 participants in total. It began in 2021-03-16 with a primary completion date of 2027-03-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of this observational study is the creation of a national multiple myeloma registry to monitor the current routine clinical practice in Italy and describe the standard of care adopted for the diagnosis and treatment of patients with multiple myeloma in the different Italian hematology centers.

Eligibility Criteria

Inclusion Criteria: * Patients of both sexes * Age ≥ 18 years * Diagnosis of active/symptomatic multiple myeloma (according to CRAB and biological parameters) no earlier than 1st January 2019 * Able and willing to sign an informed consent form Exclusion Criteria: * None considered

Contact & Investigator

Central Contact

Mario Boccadoro

✉ clinicaltrialoffice@emnitaly.org

📞 +390110243236

Frequently Asked Questions

Who can join the NCT05001087 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Multiple Myeloma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05001087 currently recruiting?

Yes, NCT05001087 is actively recruiting participants. Contact the research team at clinicaltrialoffice@emnitaly.org for enrollment information.

Where is the NCT05001087 trial being conducted?

This trial is being conducted at Florence, Italy, Ancona, Italy, Bari, Italy, Bari, Italy and 11 additional locations.

Who is sponsoring the NCT05001087 clinical trial?

NCT05001087 is sponsored by Fondazione EMN Italy Onlus. The trial plans to enroll 1,900 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology